Skip to main content

HEALTH

  • Boehringer Ingelheim launches Dulcolax for women

    RIDGEFIELD, Conn. — Boehringer Ingelheim last week announced the launch of Dulcolax Laxative Tablets for Women — tablets that are "comfort-coated" to protect a woman's stomach so the active ingredient, bisacodyl, is released only in the large intestine — to correspond with National Women's Health Week.

  • Prevalence of prediabetes, diabetes among adolescents on the rise

    NEW YORK — Being overweight and obesity during adolescence are associated with an increased risk for cardiovascular disease risk factors, especially prediabetes and diabetes, according to researchers.

  • BD introduces syringe with smaller needle for diabetes patients

    FRANKLIN LAKES, N.J. — Medical supply manufacturer BD has released a syringe with a shorter needle designed to reduce discomfort in patients with diabetes who must inject insulin, the company said Tuesday.

    BD announced the introduction of the ultra-fine 6mm needle, saying more than 80% of patients expressed a preference for it in trials, and a recent article published by the American Association of Diabetes Educators recognized the safety and efficacy of shorter needles.

    The needle is designed to deliver insulin subcutaneously in adults and children.

  • Cirrus Healthcare launches line of Hello Kitty antimicrobial earplugs

    COLD SPRING HARBOR, N.Y. — Cirrus Healthcare Products earlier this month announced the launch of its Hello Kitty-licensed earplugs for swimming and sound protection. The earplugs are individually printed with the cartoon characters encouraging young children to wear ear protection while swimming.

  • FITT Highway Products launches energy shot line in Calif., Nevada convenience stores

    MISSION VIEJO, Calif. — FITT Highway Products on Tuesday announced the initial launch of its F.I.T.T. Energy products — three 2-oz. energy shots — through convenience stores in California and Nevada.

  • Novo Nordisk's Levemir approved for children ages 2 to 5 years

    PRINCETON, N.J. — The Food and Drug Administration has approved a treatment for Type 1 diabetes in children ages 2 to 5 years.

    Drug maker Novo Nordisk announced Tuesday the additional approval of Levemir (insulin detemir [rDNA origin]). The insulin already was approved for Type 1 diabetes in older children and adults and Type 2 diabetes in adults, and the drug maker said the new FDA approval made Levemir the only basal insulin analog for use in the 2 to 5 year age group.

  • Dr. Reddy's launches heartburn treatment

    HYDERABAD, India — Dr. Reddy's Labs has launched a generic version of a popular over-the-counter drug for treating heartburn, the company said Monday.

    Dr. Reddy's announced the launch of lansoprazole delayed-release capsules in the 15-mg strength in pack sizes of 14, 28 and 42. The drug is a generic version of Novartis Consumer Health's Prevacid 24 HR capsule brand, which had sales of $115 million during the 12-month period ended in March, according to SymphonyIRI InfoScan Reviews.

  • McNeil Consumer recalls one lot of Imodium on wholesale level due to damaged package

    FORT WASHINGTON, Pa. — McNeil Consumer Healthcare on Thursday informed its wholesale customers that it is voluntarily recalling one lot of Imodium multi-symptom relief 18 caplets due to a packaging issue that may have impacted a limited number of blister units in this lot.

    The product is being recalled at the wholesale level only, and not from consumers or from store shelves, as there are no safety concerns or adverse events related to the reason for the recall. The lot number (CMF023) for the recalled product can be found on the side of the product box.

X
This ad will auto-close in 10 seconds